Is the Innovation Drought Over?
New FDA and medical device industry partnership
Heart-Powered Pacemaker
Takeda Adds Jobs in La Jolla
The Pharma Coupon Strategy
According to new data from the US Food and Drug Administration, the decade-long drought of new drug innovation may be at an end.
In a consolidated effort to help speed-up the medical device review process, improve patient safety and boost investment towards research efforts, several organizations have come together to form a new nonprofit organization.
Engineers from the University of Michigan in Ann Arbor have developed an innovative pacemaker that is powered by a person’s heartbeat.
With the recent acquisition of Envoy Therapeutics, Takeda Pharmaceuticals brings 20 biotech jobs to La Jolla, California – part of the San Diego biocluster.
According to a report from the Associated Press, offering coupons for brand name drugs could be the new go-to strategy for pharma companies looking to extend the shelf life of their products.